Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Motohashi H, OConnor T, Katsuoka F, Engel JD, Yamamoto M
Attention deficit/hyperactivity disorder as an associated feature in OCTN2 deficiency with novel deletion (p.T440-Y449)
In the treatment of neonatal respiratory distress syndrome, the application of carnitine has the potential to reduce the need for surfactant, shorten the duration of mechanical ventilation, and reduce the incidence of bronchopulmonary dysplasia [303]
Particularly valuable during times of elevated oxidative stress
US$ 25.13
US$ 24.92
US$ 29.63
US$ 28.17
US$ 20.41
US$ 28.16
US$ 21.49
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
